Preferential eosinophil chemotactic activity exhibiting a molecular weight comparable to that released from sensitized human lung fragments challenged with specific antigen and designated eosinophil chemotactic factor of anaphylaxis has been isolated from extracts of human lung fragments by sequential purification on Sephadex G-25, Dowex-1, Sephadex G-10, and paper chromatography. Two eosinophilotactic tetrapeptides of amino acid sequence ValGly-Ser-Glu and Ala-Gly-Ser-Glu were recovered from the extracts in 4-12% overall yield of the low molecular weight peak from Sephadex G-25. Purified eosinophil chemotactic factor of anaphylaxis and the synthetic tetrapeptides were maximally active in amounts from 0.1 to 1.0 nmo per chemotactic chamber, and the activity was dependent on both the NHrterminal and the COOH-terminal residues. Both natural and synthetic peptides were preferentially chemotactic for eosinophils and rendered them unresponsive to a subsequent stimulus.
The eosinophil chemotactic factor of anaphylaxis (ECF-A) was discovered in 1971 as a mediator released during immediate hypersensitivity reactions in guinea pig (1) and human (2) lung slices. ECF-A was subsequently recognized to be present totally preformed in rat mast cells in association with the granules (3), human leukemic basophils (4) , and mast cell-rich tissues such as human lung and nasal polyps (3, 5) . The release of ECF-A from human tissue by IgE-dependent mechanisms has biochemical requirements and is modulated by the intracellular levels of cyclic nucleotides in a manner comparable to histamine release from the same tissues (5, 6) . The activities of ECF-A are preferentially directed to eosinophils as compared to neutrophils and mononuclear leukocytes and include chemotaxis (1, 2, 7), chemotactic deactivation (8) , stimulation of the hexose monophosphate shunt (8) , and release of granular enzymes (9) . ECF-A obtained by extraction or IgE-dependent reactions of human lung tissue or rat mast cells exhibited a molecular weight of approximately 500 by filtration on Sephadex G-25 (3) , was inactivated by digestion with subtilisin or Pronase but not with trypsin or chymotrypsin (10) , and was composed of two anodal peaks of activity on high voltage electrophoresis at neutral pH (7) . Low molecular weight acidic peptides with ECF-A activity have been isolated from human lung tissue for compositional and sequence analysis and, based on their apparent structure, synthetic peptides have been prepared that possess specific ECF-A-like functions at comparable concentrations.
MATERIALS AND METHODS Dowex AG-1-X8, 200-400 mesh, and Bio-Beads S-X1 chloromethylated resin, 200-400 mesh (Bio-Rad Laboratories, Abbreviations: ECF-A, eosinophil chemotactic factor of anaphylaxis; hpf, high power field; dansyl chloride, 1-dimethylamino-naphthalene-5-sulfonyl chloride; BOC, t-butoxycarbonyl. 4123 Richmond, Calif.), Sephadex G-25, Sephadex G- 10 (11) .
Chemotaxis. Blood from normal subjects or patients with peripheral blood hypereosinophilia of 20-95% was incubated for 45 min at 370 with citrate anticoagulant and dextran to sediment the erythrocytes (12) . The leukocyte-rich supernatant plasma was removed and centrifuged at 100 X g for 10 min at room temperature. The leukocyte pellet was either washed and suspended in Medium 199 made 0.4% in ovalbumin and 0.01 M in Tris-HCl pH 7.4 (Medium 199-ovalbumin) and used directly in the chemotactic assays, or was used as a source of a specific leukocyte population. Eosinophils were enriched by centrifugation on metrizoate cushions (13) , and neutrophils and mononuclear leukocytes were purified by centrifugation on Ficoll-Hypaque cushions (14) , then washed and resuspended in Medium 199-ovalbumin. Chemotaxis was assessed by a modification (12) of the Boyden micropore filter technique (15) . One ml of cell suspension in Medium 199-ovalbumin containing 3.5 b 0.5 X 106 eosinophils, 2.5 + 0.5 X 106 neutrophils, or 3.0 4 0.5 X 106 mononuclear leukocytes was introduced into each polystyrene disposable chemotactic chamber (Adaps, Inc., Dedham, Mass.) fitted with a 3-,um pore filter for assessment of eosinophil and neutrophil chemotaxis, and an 8-,um pore filter for mononuclear leukocyte chemotaxis; the filters separated the cells from the chemotactic factors contained in the lower compartment in 1 ml of Medium 199-ovalbumin (1, 3). After a 2 Ik to 3 hr incubation at 370, the filters were removed, fixed, and stained as described (1, 12) . Leukocytes that migrated into the filters were counted microscopically in 10 high power fields (hpf), five from each of duplicate filters, at a fixed depth in the range of 50-90 ,um from the cell source. The counting depth was selected to achieve a background count of 2 (17) . All papers were prewashed for 24 hr with the appropriate solvents. Strips of paper 2 cm wide were eluted with 3-4 ml of 0.01 M NH40H, and the samples were relyophilized twice from 2 ml of distilled water. Ninhydrin determination of portions of eluates from Dowex-1 or paper followed a standard method (18) . Treatment of ECF-A with 1.5 X 10-4 M periodic acid in 0.001 M NH4 acetate, pH 7.2, for 6 hr at 25°was followed by the addition of sodium ascorbate to a final concentration of 3.0 X 10-4 M before assay (19) . Amino-Acid Analysis and Sequence Determination. Amino-acid analyses were done according to the method of Spackman et al. (20) with a Beckman model 120C automatic amino acid analyzer which demonstrates a precision of ±L3% in the 2-10 nmol range (21) . Peptides were hydrolyzed with 0.25 ml of 6 M HCI in sealed evacuated tubes at 105°f or 30 hr. Prior performic acid oxidation or the addition of phenol was utilized to seek sulfur-containing amino acids, and tyrosine, respectively (22, 23) .
The amino-acid sequence of purified peptides was analyzed by dansylation of the amino-terminal residue of a portion of each specimen with dansyl chloride according to the method of Gray (24) and Edman degradation of the remainder of the sample to expose the next amino acid for dansylation. Dansyl-peptides were hydrolyzed with 6 M HC1 in 5 X 50 mm tubes flushed with N2 and sealed and the dansylamino acids were identified by two-dimensional chromatography on polyamide sheets (25, 26) . Sequential Edman degradation and dansylation were carried out until either the quantity of dansyl-amino acid was too small for identification or multiple dansyl-amino acids were seen. Sequence analysis from the COOH-terminus was conducted by either hydrazinolysis (27) or carboxypeptidase A digestion with identification of the amino acids liberated with the Beckman amino-acid analyzer. Selective tritiation of the COOHterminal residue followed by hydrolysis and chromatographic identification of the labeled amino acid was also used (28) .
Peptide Synthesis. Reaction vessels, shaker, and other accessories for the manual solid phase synthesis of peptides were obtained from Schwarz/Mann (Orangeburg, N.Y.). Three grams of chloromethylated resin (0.89 mmol of chloride per g) were reacted with a 2-fold molar excess of the cesium salt of BOC-Glu-O-benzyl ester, and then BOC-Ser-O-benzyl ester and BOC-Gly were successively coupled to.
each deprotected NH2-terminus with a 3-fold molar excess of the next BOC-amino acid and dicyclohexylcarbodiimide in CH2CI2 (29) . Each cycle was performed as described (29, 30) except that the coupling reaction was carried out for 12 hr, the deprotection reaction used 25% (v/v) trifluoroacetic acid-CH2Cl2 for 30 min, and the washing after deprotection consisted of 33% dioxane in CH2Gl2 in alternate washes with CH2Gl2. The completeness of deprotection and coupling was assessed by determination of total resin-free amine with chloride titrations (31). The 2.15 mmol of BOC-Gly-Ser-Gluresin synthesized was divided into three equal portions, of which one was coupled with BOC-Val, one with BOC-Ala and one left unreacted, after which each was cleaved from the resin with HBr-trifluoroacetic acid (29) . The peptides were freed of volatile contaminants by stepwise evaporation from CH2Gl2, ethanol, 0.1 M acetic acid, and water, purified on Sephadex G-10 in 0.01 M NH40H and on Dowex-1 as for ECF-A, and analyzed for amino-acid composition.
RESULTS
Extraction and purification of human lung ECF-A The extraction of human lung fragments with either acidicbutanol or alkaline Tyrode's buffer yielded large quantities of eosinophil chemotactic activity with a range for four samples of 710-1080 net eosinophils/hpf per g of lung tissue with acidic-butanol and 420-760 net eosinophils/hpf per g of lung with alkaline Tyrode's buffer. Sephadex G-25 gel filtration of extracts obtained by either procedure revealed considerable heterogeneity in molecular size of the eosinophil chemotactic activity. The major peak of activity of approximate molecular weight 300-1000 coincided with the peak of preferential eosinophil chemotactic activity released by IgE-mediated reactions (3, 7 gave less than one-half the activity obtained with the aforementioned two solvents, a result consistent with the acidic nature of the active peptides as previously shown by electrophoresis (7). The 300-1000 molecular weight peak of eosinophil chemotactic activity recovered from Sephadex G-25 was therefore purified by anion exchange chromatography on Dowex-1, where the bulk of the ECF-A eluted in a broad peak at pH 3.0-2.2. The activities eluting at pH 3.0-2.6 and pH 2.6-2.2 were separately pooled and filtered on Sephadex G-10. The single peaks obtained were then subjected to descending paper chromatography (Fig. 1) 3 .00-9.94 for the alanyl peptide and 7.88 L 0.54, 7.30-8.36 for the valyl peptide. The nmol recovery of glycine was arbitrarily assigned a value of 1.00 in assessing the contribution of individual residues. The residue value for valine in the alanyl peptide was 0.10 1 0.15 and for alanine in the valyl peptide was 0.36 I 0.16. Sequence procedures were: -, dansyl-Edman reaction; ---, hydrazinolysis; *, carboxypeptidase A digestion. Immunology: Goetzl and paper, and co-electrophoresed on paper in the same region as natural ECF-A when assessed functionally. Both tetrapeptides were chemotactic for human eosinophils with maximum activity in the 10-6-10-7 M range (Fig. 3) (Fig. 1) . Although the eosinophilotactic activity extracted by extensive sonication in acidic-butanol or alkaline-Tyrode's solvents was heterogeneous on initial Sephadex G-25 chromatograms, material in the 300-1000 molecular weight range was selected for further purification since the activity released immunologically and designated ECF-A filtered within this region (1, 3) . Whereas, Sephadex G-25 peaks of ECF-A obtained by either extraction or IgEdependent release gave broad peaks of activity on either Dowex-1 or paper chromatography, subdivision of the activity eluted from Dowex-1 revealed that the more acidic pool showed greater hydrophobicity (Fig. 1) . Amino-acid composition and sequence analysis revealed that the more acidic and hydrophobic material was predominantly a tetrapeptide Val-Gly-Ser-Glu, and that the less hydrophobic overlapping (7) . The stimuli for deactivated leukocytes were kallikrein for neutrophils, ECF-A for eosinophils, and C5a for mononuclear leukocytes at the same concentrations as above.
Proc. Nat. Acad. Sci. USA 72 (1975) Proc. Nat. Acad. Sci. USA 72 (1975) 4127 peak of activity was attributable to a structurally related tetrapeptide Ala-Gly-Ser-Glu (Fig. 2) . The presence of lipid eosinophilotactic factors in the mixture of purified peptides was unlikely in view of the failure of Rhodamine 6-G to stain any relevant area of paper chromatograms or electrophoresis patterns (33) . Periodic acid treatment of preparations of ECF-A failed to modify eosinophil chemotactic activity, thereby eliminating a functional contribution of carbohydrate moieties (19) . The overall yield of 4-12% of the activity from the low-molecular-weight region of the initial Sephadex G-25 chromatogram reflects cumulative losses at each purification step since no minor peaks representing functional heterogeneity were encountered. No differences were seen between the extracted material and that released immunologically and originally described as ECF-A.
The valyl-and alanyl-tetrapeptides were synthesized and shown to have eosinophil chemotactic and deactivating activity and specificity comparable to that of natural ECF-A (Fig. 3, Table 1 ). Purified ECF-A preparations were active at 0.6-0.7 nmol per chamber, and 10-6 M synthetic tetrapeptides which provide 1 nmol per chamber gave similar activity (Fig. 3) . Purification of the synthetic peptides and extracted ECF-A revealed that the peptide peaks and eosinophilotactic activity had the same characteristics on Dowex-1, Sephadex G-10, and paper electrophoresis and chromatography.
The inactivation of ECF-A and synthetic tetrapeptide eosinophil chemotactic activity by limited digestion with aminopeptidase M reveals that the NH2-terminal sequence is critical to ECF-A activity. This conclusion is supported by the marginal activity of the COOH-terminal tripeptide (Fig.  3) . The COOH-terminal glutamic residue is also necessary since carboxypeptidase-A digestion reduces the chemotactic action of ECF-A. The ninhydrin positivity of eosinophil peaks during ECF-A purification, the susceptibility to aminopeptidase M digestion, and the reactivity on dansylation of the NH2-terminus provide evidence that ECF-A has a free NH2-terminus.
Purified and synthetic ECF-A share features with the small peptide chemotactic factors, bacterial soluble factors (34) , and formyl methionyl peptides (35) , such as maximum activity in nanomolar amounts, high-dose inhibition, and acidic and hydrophobic amino-acid residues (34, 35) . In apparent contrast to these other peptide factors, ECF-A does not have a blocked NH2-terminus, preferentially attracts eosinophils, and is capable of deactivating eosinophils to a subsequent chemotactic stimulus (8) . Since the alanyl-and valyl-tetrapeptides share a hydrophobic NH2-terminus and an acidic COOH-terminus, it is possible that the NH2-terminus recognizes an eosinophil membrane receptor placing the acidic residue close to the cell surface. Such charge localization may perturbate the membrane to lead to pseudopod formation and directed mobility. Definition of ECF-A structure makes feasible the preparation of analogs with residue substitutions and size variations for further analysis of the structural requirements for eosinophil stimulation and possible separation of responses.
